scholarly journals Defining comprehensive biomarker‐related testing and treatment practices for advanced non‐small‐cell lung cancer: Results of a survey of U.S. oncologists

2021 ◽  
Author(s):  
Kathryn F. Mileham ◽  
Caroline Schenkel ◽  
Suanna S. Bruinooge ◽  
Janet Freeman‐Daily ◽  
Upal Basu Roy ◽  
...  
2007 ◽  
Vol 2 (11) ◽  
pp. 1029-1035 ◽  
Author(s):  
Geoffrey R. Oxnard ◽  
Panos Fidias ◽  
Alona Muzikansky ◽  
Lecia V. Sequist

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e19119-e19119
Author(s):  
Khalid Salim Al-Baimani ◽  
Zuhaib Mir ◽  
Tinghua Zhang ◽  
Hannah Jonker ◽  
Elise Azzi ◽  
...  

2019 ◽  
Vol 08 (02) ◽  
pp. 073-079
Author(s):  
Nikhil Suresh Ghadyalpatil ◽  
Avinash Pandey ◽  
Iyer Krishnamani ◽  
Chilukuri Srinivas ◽  
Shabnam J. Rafiq ◽  
...  

Abstract Lung cancer has been the most common cancer in the world for several decades. The non-small cell lung cancer (NSCLC) constitutes approximately about 80% of the total cases of lung cancer. Therapeutic interventions in NSCLC have shifted to the target-based approach from histology-based approach, and this has completely changed the face of the management of NSCLC. Developing countries, such as India, have very limited data compiled about the prevalence and treatment practices of lung cancer, despite a large burden of the disease. However, in recent times, there has been a lot of data generated in this regard. This article is an attempt to collate and shine light on the available data for the first-line treatment of NSCLC in India keeping in mind the current standards of care in this area.


2016 ◽  
Vol 22 ◽  
pp. 176
Author(s):  
Genevieve Streb ◽  
Narjust Duma ◽  
Natasha Piracha ◽  
Sejal Kothadia ◽  
Komal Patel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document